Sponsor Pipeline

Biotroy Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07107204 A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies Relapsed or Refractory Hematologic Malignancies Not Yet Recruiting
Phase 1
NCT07107178 A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma Advanced Melanoma Not Yet Recruiting
NCT07110363 A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer Advanced Malignant Solid Tumor Not Yet Recruiting
Disease Areas
Melanoma (1) Leukemia (1) Multiple Myeloma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1) Lung Cancer (1)
Get alerts when Biotroy Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free